Adage Capital Partners
HELP

Adage Capital Partners’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Adage Capital Partners’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Buy
3,060,000
+2,360,000
+337% +$11.8M 0.03% 494
2026
Q1 		$3.36M Hold
700,000
– – 0.01% 804
2025
Q4 		$5.73M Buy
+700,000
New +$4.51M 0.01% 743

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Adage Capital Partners's HELP Position: Q2 2026 in Review

Adage Capital Partners increased its Helus Pharma Inc. Common Stock (HELP) stake by 337% in Q2 2026, buying an estimated $11.8M and bringing the position to 3,060,000 shares worth $20.2M. The position accounts for 0.03% of the portfolio, ranked #494.

Adage Capital Partners first reported a position in HELP in Q4 2025 and has held it in 3 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Adage Capital Partners held 3,060,000 shares of Helus Pharma Inc. Common Stock worth $20.2M as of Q2 2026.
  • Adage Capital Partners bought 2,360,000 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $11.8M.
  • Helus Pharma Inc. Common Stock made up 0.03% of Adage Capital Partners's portfolio in Q2 2026, its #494 holding.
  • Adage Capital Partners first reported a position in Helus Pharma Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.